Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Iron Status May Not Affect Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study. | Front Genet | 2021 | 33747043 | PubTator, text mining | PubMed |
| A retrospective analysis of actionable pharmacogenetic/genomic biomarker language in FDA labels. | Clin Transl Sci | 2021 | 33742770 | PubTator, text mining | PubMed |
| A clinical study on the factors associated with nasopharyngeal carcinoma among the Chinese population. | Exp Ther Med | 2021 | 33732348 | PubTator, text mining | PubMed |
| Co-occurrence of orofacial clefts and clubfoot phenotypes in a sub-Saharan African cohort: Whole-exome sequencing implicates multiple syndromes and genes. | Mol Genet Genomic Med | 2021 | 33719213 | PubTator, text mining | PubMed |
| Mining of RNA Methylation-Related Genes and Elucidation of Their Molecular Biology in Gallbladder Carcinoma. | Front Oncol | 2021 | 33718182 | PubTator, text mining | PubMed |
| Association of NAT2 genetic polymorphism with the efficacy of Neurotropin® for the enhancement of aggrecan gene expression in nucleus pulposus cells: a pilot study. | BMC Med Genomics | 2021 | 33706752 | PubTator, text mining | PubMed |
| Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis. | Biomed Res Int | 2021 | 33688500 | PubTator, text mining | PubMed |
| Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes. | Mediators Inflamm | 2021 | 33688304 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing in Patients Affected by Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Reveals New Variants Potentially Contributing to the Phenotype. | Pharmgenomics Pers Med | 2021 | 33688237 | PubTator, text mining | PubMed |
| NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis. | Pharmacogenet Genomics | 2021 | 33675325 | PubTator, text mining | PubMed |
| Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs. | Clin Pharmacokinet | 2021 | 33674941 | PubTator, text mining | PubMed |
| Maternal Risk Factors Associated with Limb Reduction Defects: Data from the Polish Registry of Congenital Malformations (PRCM). | Children (Basel) | 2021 | 33673226 | PubTator, text mining | PubMed |
| Energy Drinks and Sports Performance, Cardiovascular Risk, and Genetic Associations; Future Prospects. | Nutrients | 2021 | 33668219 | PubTator, text mining | PubMed |
| Penalized partial least squares for pleiotropy. | BMC Bioinformatics | 2021 | 33627076 | PubTator, text mining | PubMed |
| A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis. | Clin Pharmacokinet | 2021 | 33615419 | PubTator, text mining | PubMed |
| The expression pattern of N-acetyltransferase 1 in healthy human skin. | Contact Dermatitis | 2021 | 33609293 | PubTator, text mining | PubMed |
| Translating genetic association of lipid levels for biological and clinical application. | Cardiovasc Drugs Ther | 2021 | 33604704 | PubTator, text mining | PubMed |
| Gene-environment interactions between air pollution and biotransformation enzymes and risk of birth defects. | Birth Defects Res | 2021 | 33569925 | PubTator, text mining | PubMed |
| ApmA Is a Unique Aminoglycoside Antibiotic Acetyltransferase That Inactivates Apramycin. | mBio | 2021 | 33563840 | PubTator, text mining | PubMed |
| Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. | Int J Mol Sci | 2021 | 33562824 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=36